Delivery Order SPE2DB22D2007-SPE2DB25FJ5DV
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Promacta 75 mg tablets in quantities of 30 units. This firm fixed-price contract, valued at $36,088.89, represents a non-set-aside, competitively awarded procurement supporting federal medical supply requirements. The order is scheduled for completion by October 9, 2025, with performance originating from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $26,503.50 to AmerisourceBergen Drug Corp for the supply of Promacta 12.5 mg tablets in quantities of 30 units. This firm fixed price contract, awarded on May 22, 2025, with an ultimate completion date of June 13, 2025, represents a non-set-aside competitive award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $8,026.53 to AmerisourceBergen Drug Corp for the supply of Promacta 50 mg tablets in quantities of 30 units. The contract, issued on July 14, 2025, with an ultimate completion date of August 4, 2025, utilizes firm fixed-price pricing with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child...
- The Defense Logistics Agency awarded a delivery order valued at $8,026.53 to AmerisourceBergen Drug Corp for the supply of Promacta 50 mg tablets (30-tablet units) on July 22, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order, executed without a set-aside designation, was competitively awarded and represents a transaction under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX). The contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Promacta 12.5 mg tablets (30-count units) under a firm fixed price contract valued at $13,251.75, with completion targeted for October 6, 2025. This competitively awarded, non-set-aside delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract action under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for PROMACTA 75 mg tablets (30-count units) on July 22, 2025, with a ceiling value of $24,059.26 and firm fixed pricing. This non-set-aside, competitively awarded contract represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be delivered to the...
- The Defense Logistics Agency awarded a $24,059.26 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Promacta 75 mg tablets in units of 30. This non-set-aside award, designated as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, represents a routine pharmaceutical procurement supporting federal medical supply chain requirements. The order is scheduled for completion by September 8,...
- The Defense Logistics Agency awarded a delivery order valued at $8,836.12 to AmerisourceBergen Drug Corp for the supply of Promacta 25 mg tablets (30-count packaging) with a completion date of September 4, 2025. The competitive, firm fixed-price award was issued on August 13, 2025, with no set-aside designation. AmerisourceBergen will perform the work at its corporate office located in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Promacta 50 mg tablets (30-count units) with a ceiling value of $8,026.53. This firm fixed-price delivery order, with an ultimate completion date of September 18, 2025, represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract vehicle with the DLA. The award was competitively awarded with no set-aside designation and will be performed at...
- The Defense Logistics Agency awarded a $4,418.06 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Promacta 25 mg tablets (30-count units). The contract, which is a child delivery order under a larger indefinite delivery vehicle, carries an ultimate completion date of August 18, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ5DVDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $48,118.52 to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Promacta 75 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract calls for completion by October 10, 2025, with fulfillment from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, holds a substantial $999.999 billion Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX) extending through December 2026. This comprehensive global pharmaceutical support vehicle enables the company to supply a broad range of medications, vaccines, and medical supplies to support military healthcare systems worldwide. The current delivery order for Promacta, a specialty pharmaceutical product used in hematologic treatment, represents routine fulfillment under this larger contract vehicle that serves the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $48.1k | 9/19/25 |